Long-term effects of maternal resveratrol intake during lactation on cholesterol metabolism in male rat offspring

References

• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72(1–2):248–254.
   PubMed Web of Science ®Google Scholar
• Brookins Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS. 2009. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med. 46(12):1589–1597.
   PubMed Web of Science ®Google Scholar
• Brown MS, Faust JR, Goldstein JL, Kaneko I, Endo A. 1978. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem. 253(4):1121–1128.
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. 1983. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest. 72(3):743–747.
   PubMed Web of Science ®Google Scholar
• Chang T-Y, Li B-L, Chang CCY, Urano Y. 2009. Acyl-coenzyme A:cholesterol acyltransferases. AJP Endocrinol Metab. 297(1):E1–E9.
   PubMed Web of Science ®Google Scholar
• Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. 1991. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 303(6797):276–282.
   PubMedGoogle Scholar
• Chiang J. 2009. Bile acids: regulation of synthesis. J Lipid Res. 50(10):1955–1966.
   PubMed Web of Science ®Google Scholar
• Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY. 2008. Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophys Res Commun. 367(1):190–194.
   PubMed Web of Science ®Google Scholar
• Cong R, Jia Y, Li R, Ni Y, Yang X, Sun Q, Parvizi N, Zhao R. 2012. Maternal low-protein diet causes epigenetic deregulation of HMGCR and CYP7α1 in the liver of weaning piglets. J Nutr Biochem. 23(12):1647–1654.
   PubMed Web of Science ®Google Scholar
• De Amicis F, Giordano F, Vivacqua A, Pellegrino M, Panno ML, Tramontano D, Fuqua SAW, Andò S. 2011. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J. 25(10):3695–3707.
   PubMed Web of Science ®Google Scholar
• Do GM, Kwon EY, Kim HJ, Jeon SM, Ha TY, Park T, Choi MS. 2008. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun. 374(1):55–59.
   PubMed Web of Science ®Google Scholar
• Duncan EA, Brown MS, Goldstein JL, Sakai J. 1997. Cleavage site for sterol-regulated protease localized to a Leu-Ser bond in the lumenal loop of sterol regulatory element-binding protein-2. J Biol Chem. 272(19):12778–12785.
   PubMed Web of Science ®Google Scholar
• Ehara T, Kamei Y, Yuan X, Takahashi M, Kanai S, Tamura E, Tsujimoto K, Tamiya T, Nakagawa Y, Shimano H, et al. 2015. Ligand-activated PPARα-dependent DNA demethylation regulates the fatty acid β-oxidation genes in the postnatal liver. Diabetes. 64(3):775–784.
   PubMed Web of Science ®Google Scholar
• Emberson J, Whincup PH, Morris RW, Walker M. 2003. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J. 24(19):1719–1726.
   PubMed Web of Science ®Google Scholar
• Franke AA, Halm BM, Custer LJ, Tatsumura Y, Hebshi S. 2006. Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr. 84(2):406–413.
   PubMed Web of Science ®Google Scholar
• Geelen MH, Gibson D, Rodwell V. 1986. Hydroxymethylglutaryl-CoA reductase-the rate-limiting enzyme of cholesterol biosynthesis. A report of a meeting held at Nijenrode Castle, Breukelen, The Netherlands, August 24, 1985. FEBS Lett. 201(2):183–186.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature. 343(6257):425–430.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Brown MS. 2015. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 161(1):161–172.
   PubMed Web of Science ®Google Scholar
• Gordon DA, Jamil H. 2000. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim Biophys Acta Mol Cell Biol Lipids. 1486(1):72–83.
   Web of Science ®Google Scholar
• Grau M, Subirana I, Elosua R, Fitó M, Covas M-I, Sala J, Masiá R, Ramos R, Solanas P, Cordon F, et al. 2010. Why should population attributable fractions be periodically recalculated?: an example from cardiovascular risk estimation in southern Europe. Prev Med (Baltim). 51(1):78–84.
   Web of Science ®Google Scholar
• Henin N, Vincent MF, Gruber HE, Van den Berghe G. 1995. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 9(7):541–546.
   PubMed Web of Science ®Google Scholar
• Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H. 1998. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest. 101(11):2331–2339.
   PubMed Web of Science ®Google Scholar
• Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, et al. 2008. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem. 283(29):20015–20026.
   PubMed Web of Science ®Google Scholar
• Hussain MM, Rava P, Walsh M, Rana M, Iqbal J. 2012. Multiple functions of microsomal triglyceride transfer protein. Nutr Metab (Lond). 9(1):14–19.
   PubMedGoogle Scholar
• Imano H, Noda H, Kitamura A, Sato S, Kiyama M, Sankai T, Ohira T, Nakamura M, Yamagishi K, Ikeda A, et al. 2011. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Prev Med (Baltim). 52(5):381–386.
   Web of Science ®Google Scholar
• Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO. 1986. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J. 112(4):825–836.
   PubMed Web of Science ®Google Scholar
• Kataoka S, Norikura T, Sato S. 2018. Maternal green tea polyphenol intake during lactation attenuates kidney injury in high-fat-diet-fed male offspring programmed by maternal protein restriction in rats. J Nutr Biochem. 56:99–108.
   PubMed Web of Science ®Google Scholar
• Khymenets O, Rabassa M, Rodríguez-Palmero M, Rivero-Urgell M, Urpi-Sarda M, Tulipani S, Brandi P, Campoy C, Santos-Buelga C, Andres-Lacueva C. 2016. Dietary epicatechin is available to breastfed infants through human breast milk in the form of host and microbial metabolites. J Agric Food Chem. 64(26):5354–5360.
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127(6):1109–1122.
   PubMed Web of Science ®Google Scholar
• Lan F, Cacicedo JM, Ruderman N, Ido Y. 2008. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation . J Biol Chem. 283(41):27628–27635.
   PubMed Web of Science ®Google Scholar
• Li Y, He Y, Qi L, Jaddoe VW, Feskens EJM, Yang X, Ma G, Hu FB. 2010. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes. 59(10):2400–2406.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy J-J, et al. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13(4):376–388.
   PubMed Web of Science ®Google Scholar
• Liu S, Jing F, Yu C, Gao L, Qin Y, Zhao J. 2015. AICAR-induced activation of AMPK Inhibits TSH/SREBP-2/HMGCR pathway in liver. PLoS One. 10(5):e0124951.
   PubMed Web of Science ®Google Scholar
• Marshall SM, Gromovsky AD, Kelley KL, Davis MA, Wilson MD, Lee RG, Crooke RM, Graham MJ, Rudel LL, Brown JM, et al. 2014. Acute sterol O-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion. PLoS One. 9(6):e98953.
   PubMed Web of Science ®Google Scholar
• Ravelli A, van der Meulen J, Michels R, Osmond C, Barker D, Hales C, Bleker O. 1998. Glucose tolerance in adults after prenatal exposure to famine. Lancet. 351(9097):173–177.
   PubMed Web of Science ®Google Scholar
• Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B. 1990. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 323(4):224–228.
   PubMed Web of Science ®Google Scholar
• Ribaroff GA, Wastnedge E, Drake AJ, Sharpe RM, Chambers T. 2017. Animal models of maternal high fat diet exposure and effects on metabolism in offspring: a meta-regression analysis. Obes Rev. 18(6):673–686.
   PubMed Web of Science ®Google Scholar
• Romaszko E, Wiczkowski W, Romaszko J, Honke J, Piskula MK. 2014. Exposure of breastfed infants to quercetin after consumption of a single meal rich in quercetin by their mothers. Mol Nutr Food Res. 58(2):221–228.
   PubMed Web of Science ®Google Scholar
• Ros P, Díaz F, Freire-Regatillo A, Argente-Arizón P, Barrios V, Argente J, Chowen JA. 2018. Resveratrol intake during pregnancy and lactation modulates the early metabolic effects of maternal nutrition differently in male and female offspring. Endocrinology. 159(2):810–825.
   PubMed Web of Science ®Google Scholar
• Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS, Goldstein JL. 1996. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell. 85(7):1037–1046.
   PubMed Web of Science ®Google Scholar
• Sakakura Y, Shimano H, Sone H, Takahashi A, Inoue N, Toyoshima H, Suzuki S, Yamada N, Inoue K. 2001. Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun. 286(1):176–183.
   PubMed Web of Science ®Google Scholar
• Samuelsson A-M, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EHJM, Piersma AH, Ozanne SE, Twinn DF, Remacle C, et al. 2008. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension. 51(2):383–392.
   PubMed Web of Science ®Google Scholar
• Sanchez HB, Yieh L, Osborne TF. 1995. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J Biol Chem. 270(3):1161–1169.
   PubMed Web of Science ®Google Scholar
• Sato R, Inoue J, Kawabe Y, Kodama T, Takano T, Maeda M. 1996. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J Biol Chem. 271(43):26461–26464.
   PubMed Web of Science ®Google Scholar
• Spady DK. 1992. Hepatic clearance of plasma low density lipoproteins. Semin Liver Dis. 12(4):373–385.
   PubMed Web of Science ®Google Scholar
• Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. 2000. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 284(3):311–318.
   PubMed Web of Science ®Google Scholar
• Sugiyama D, Okamura T, Watanabe M, Higashiyama A, Okuda N, Nakamura Y, Hozawa A, Kita Y, Kadota A, Murakami Y, et al. 2015. Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese Cohort Study. J Atheroscler Thromb. 22(1):95–107.
   PubMed Web of Science ®Google Scholar
• Sun L-P, Li L, Goldstein JL, Brown MS. 2005. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J Biol Chem. 280(28):26483–26490.
   PubMed Web of Science ®Google Scholar
• Sun S, Meng Q, Luo Z, Shi B, Bi C, Shan A. 2019. Effects of dietary resveratrol supplementation during gestation and lactation of sows on milk composition of sows and fat metabolism of sucking piglets. J Anim Physiol Anim Nutr. 103(3):813–821.
   PubMed Web of Science ®Google Scholar
• Sun Y, Mukai Y, Tanaka M, Saito T, Sato S, Kurasaki M. 2013. Green tea extract increases mRNA expression of enzymes which influence epigenetic marks in newborn female offspring from undernourished pregnant mother. PLoS One. 8(8):e74559.
   PubMed Web of Science ®Google Scholar
• Sun B, Purcell RH, Terrillion CE, Yan J, Moran TH, Tamashiro K. 2012. Maternal high-fat diet during gestation or suckling differentially affects offspring leptin sensitivity and obesity. Diabetes. 61(11):2833–2841.
   PubMed Web of Science ®Google Scholar
• Vega CC, Reyes-Castro LA, Rodríguez-González GL, Bautista CJ, Vázquez-Martínez M, Larrea F, Chamorro-Cevallos GA, Nathanielsz PW, Zambrano E. 2016. Resveratrol partially prevents oxidative stress and metabolic dysfunction in pregnant rats fed a low protein diet and their offspring. J Physiol (Lond). 594(5):1483–1499.
   Google Scholar
• Walker AK, Yang F, Jiang K, Ji J-Y, Watts JL, Purushotham A, Boss O, Hirsch ML, Ribich S, Smith JJ, et al. 2010. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev. 24(13):1403–1417.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) 2018. Global Health Estimates 2016: deaths by cause, age, sex, by country and by region, 2000-2016. Geneva: World Health Organization.
   Google Scholar
• Xin P, Han H, Gao D, Cui W, Yang X, Ying C, Sun X, Hao L. 2013. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem Toxicol. 52:12–18.
   PubMed Web of Science ®Google Scholar
• Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS. 2002. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell. 110(4):489–500.
   PubMed Web of Science ®Google Scholar
• Yashiro T, Nanmoku M, Shimizu M, Inoue J, Sato R. 2012. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. Atherosclerosis. 220(2):369–374.
   PubMed Web of Science ®Google Scholar
• Yuan X, Tsujimoto K, Hashimoto K, Kawahori K, Hanzawa N, Hamaguchi M, Seki T, Nawa M, Ehara T, Kitamura Y, et al. 2018. Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood. Nat Commun. 9(1):636.
   PubMedGoogle Scholar
• Yu Y, Zhang N, Jiang H, Xue W, Guo X, Xu X, Fang W, Wang H, Hua E. 2016. Resveratrol treatment improves plasma and blood glucose concentration and lipid metabolism in high-fat-fed C57BL/6J mice. Eur Food Res Technol. 242(11):1849–1856.
   Web of Science ®Google Scholar
• Zeng K, Wang Y, Yang N, Wang D, Li S, Ming J, Wang J, Yu X, Song Y, Zhou X, et al. 2017. Resveratrol inhibits diabetic-induced Müller cells apoptosis through microRNA-29b/specificity protein 1 pathway. Mol Neurobiol. 54(6):4000–4014.
   PubMed Web of Science ®Google Scholar
• Zhu L, Luo X, Jin Z. 2008. Effect of resveratrol on serum and liver lipid profile and antioxidant activity in hyperlipidemia rats. Asian Australas J Anim Sci. 21(6):890–895.
   Web of Science ®Google Scholar